gastroenterology hepatology
NAFLD Fibrosis Score (NFS)
Non-invasive scoring to identify advanced fibrosis (F3-F4) in NAFLD/MASLD patients. Avoids need for liver biopsy in many patients.
Score interpretation
Advanced fibrosis unlikely (F0-F2)
→ Low probability advanced fibrosis; lifestyle intervention; repeat NFS in 2-3 years
Indeterminate zone
→ Consider liver biopsy or FibroScan for definitive staging
Advanced fibrosis likely (F3-F4)
→ High probability advanced fibrosis; liver biopsy confirmation; refer hepatology; assess for cirrhosis complications
Interpretation bands for the NAFLD Fibrosis Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Omega-3-acid ethyl esters · Omega-3 fatty acids
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Hydroxycarbamide (Hydroxyurea) · Cytoreductive agent / Sickle cell disease / CML
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.